| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.01 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
| mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
| mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
| mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
| mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
0.02 |